Revenue
$40.4M
▼ 49.5% YoY
Net Income
-$119.7M
▼ 84.2% YoY
EPS
$-2.04
▼ 80.5% YoY
Cash
$65.3M
▼ 8.5% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Swartz Robin COO & CBO | Sell | Feb 24, 2026 | 6.5K | $3.77 | $24K | Form 4 ↗ |
Sandrock Alfred President and CEO | Sell | Feb 24, 2026 | 14.2K | $3.79 | $54K | Form 4 ↗ |
Jorgensen Nathan D. Chief Financial Officer | Sell | Feb 24, 2026 | 4.7K | $3.77 | $18K | Form 4 ↗ |
Carter Todd Alfred Chief Scientific Officer | Sell | Feb 24, 2026 | 4.2K | $3.76 | $16K | Form 4 ↗ |
Swartz Robin COO & CBO | Sell | Feb 18, 2026 | 3.9K | $3.44 | $13K | Form 4 ↗ |
Carter Todd Alfred Chief Scientific Officer | Sell | Feb 18, 2026 | 3.3K | $3.44 | $11K | Form 4 ↗ |
Sandrock Alfred President and CEO | Sell | Feb 18, 2026 | 11.7K | $3.41 | $40K | Form 4 ↗ |
Swartz Robin COO & CBO | Sell | Feb 10, 2026 | 4.6K | $3.85 | $18K | Form 4 ↗ |
Sandrock Alfred President and CEO | Sell | Feb 10, 2026 | 12.2K | $3.78 | $46K | Form 4 ↗ |
Carter Todd Alfred Chief Scientific Officer | Sell | Feb 10, 2026 | 3.5K | $3.85 | $14K | Form 4 ↗ |
Ferguson Toby Chief Medical Officer | Grant | Feb 6, 2026 | 45.0K | $0.00 | $0 | Form 4 ↗ |
Carter Todd Alfred Chief Scientific Officer | Grant | Feb 6, 2026 | 33.0K | $0.00 | $0 | Form 4 ↗ |